Inotiv, Inc. (NOTV) NASDAQ
0.26
-0.0458(-14.98%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.26
-0.0458(-14.98%)
Currency In USD
| Previous Close | 0.31 |
| Open | 0.28 |
| Day High | 0.29 |
| Day Low | 0.26 |
| 52-Week High | 3.32 |
| 52-Week Low | 0.22 |
| Volume | 1.4M |
| Average Volume | 787,598 |
| Market Cap | 9.07M |
| PE | -0.1 |
| EPS | -2.48 |
| Moving Average 50 Days | 0.28 |
| Moving Average 200 Days | 0.78 |
| Change | -0.05 |
Inotiv Provides Notice Regarding Cybersecurity Incident
GlobeNewswire Inc.
Feb 13, 2026 9:30 PM GMT
WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and resear
Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026
GlobeNewswire Inc.
Feb 04, 2026 11:30 AM GMT
WEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and resear
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
GlobeNewswire Inc.
Jan 13, 2026 2:15 PM GMT
WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and resear